```html

Verruca vulgaris (Common Wart) – A Patient‑Focused Guide

Overview

Verruca vulgaris, commonly called a “common wart,” is a benign skin growth caused by infection with certain subtypes of the human papillomavirus (HPV). These lesions most often appear on the hands, fingers, and around the nails, but they can develop on any skin surface.

• Who it affects: All ages can develop common warts, but they are most prevalent in children and adolescents (peak incidence 5–15 years). Adults can also be affected, especially those with weakened immune systems.
• Prevalence: Studies estimate that approximately 10–20 % of the population will develop at least one common wart during their lifetime. In school‑aged children, the prevalence ranges from 12 % to 16 % (CDC, 2022).

Symptoms

Common warts are usually painless, but they can cause discomfort depending on size, location, and irritation. Typical features include:

• Raised, rough surface: Small, flesh‑colored or brownish papules that feel grainy.
• Surface black dots: Tiny thrombosed capillaries (often described as “black seeds”).
• Size: Generally 1–5 mm, but can coalesce into larger plaques.
• Shape: Often dome‑shaped with a broad base; may be single or multiple.
• Location‑specific signs:
  • On fingers or knuckles: “filiform” or “digitate” warts with finger‑like projections.
  • Near nail folds: “periungual” warts that may cause nail distortion.
• Discomfort: Pain or tenderness when pressure is applied (e.g., gripping a ball).
• Spread: New warts may appear near the original lesion (autoinoculation).
• Resolution: Many warts regress spontaneously within 2 years, though some persist.

Causes and Risk Factors

Common warts result from infection of the epidermal keratinocytes by HPV types 2, 4, and 27. The virus enters through tiny cuts or abrasions.

Key risk factors

• Age: Children’s immune systems are still maturing, making them more susceptible.
• Skin trauma: Frequent hand washing, sports injuries, or occupations that cause skin breaks increase entry points.
• Moist environments: Swimming pools, gym locker rooms, and communal showers facilitate viral spread.
• Immunosuppression: Individuals with HIV, organ transplants, or on systemic steroids have higher incidence and more extensive disease.
• Close contact: Direct skin‑to‑skin contact (e.g., play‑ground activities) or sharing towels and razors.
• Genetic predisposition: Certain HLA types may affect susceptibility, though data are limited.

Diagnosis

Diagnosis is primarily clinical.

Steps in evaluation

1. Visual inspection: A clinician examines the lesion’s morphology—rough surface, black dots, location.
2. Dermoscopy (optional): A handheld dermatoscope can highlight the characteristic vascular pattern (“punctate vessels”) and help distinguish warts from other papules.
3. Biopsy (rare): When the diagnosis is uncertain—e.g., atypical appearance, rapid growth, or suspicion of malignancy—a punch or excisional biopsy is performed. Histology shows hyperkeratosis, papillomatosis, and viral cytopathic changes (koilocytosis).

Routine laboratory testing (HPV PCR, blood work) is NOT required for ordinary common warts.

Treatment Options

Because many warts resolve spontaneously, treatment decisions balance lesion burden, symptomatology, cosmetic concern, and patient preference. Below are evidence‑based modalities.

Topical agents

• Salicylic acid (SA) preparations (10–40 %): First‑line, OTC option. Works by keratolysis, gradually peeling the wart. Requires daily application for 6–12 weeks.
  Evidence: A 2020 randomized trial showed 70 % clearance after 12 weeks of 40 % SA (Cleveland Clinic).
• Cantharidin (0.7–1 %): A blistering agent applied by a clinician. Causes intra‑epidermal vesiculation; lesions usually fall off in 1–2 weeks.
• Topical immunotherapy (e.g., imiquimod 5 % cream): Stimulates local immune response; reserved for recalcitrant warts.

Cryotherapy

Liquid nitrogen (−196 °C) applied for 10–20 seconds per lesion. Success rates range from 50–80 % after 1–3 sessions (American Academy of Dermatology, 2021). May cause blistering or hypopigmentation.

Electrosurgery & Curettage

Under local anesthesia, the wart is scraped (curette) and the base cauterized. Effective for solitary, thick warts but carries risk of scarring.

Laser therapy

CO₂ or pulse‑dye lasers ablate tissue. Offers precise removal, useful for periungual warts where preservation of nail matrix is critical. Higher cost; success 70–90 %.

Intralesional immunotherapy

Injection of antigens (e.g., Candida antigen) into a distant wart stimulates systemic immunity, leading to clearance of multiple lesions. Particularly helpful in immunocompetent adults with numerous warts.

Home remedies (caution advised)

• Apple cider vinegar, duct tape occlusion, or over‑the‑counter wart‑freezing kits have limited and inconsistent evidence; they may cause skin irritation.

Lifestyle & supportive care

• Keep the area clean and dry.
• Avoid picking or scratching to prevent spread.
• Protect the wart with a waterproof bandage during swimming.

Living with Verruca vulgaris (common wart)

While warts are benign, they can affect daily activities and self‑esteem. The following tips help manage them effectively.

• Hygiene: Wash hands regularly; dry thoroughly, especially after water exposure.
• Protective barriers: Use fingertip “wart guards” or waterproof adhesive patches during sports or manual work.
• Footwear: If you develop plantar warts (a related HPV type), wear sandals in communal showers.
• Monitor: Photograph lesions at baseline and during treatment to track response.
• Emotional support: Discuss any cosmetic concerns with your clinician; options like laser therapy can improve appearance.
• Immune health: Adequate sleep, balanced diet, and stress management support the body’s natural viral clearance.

Prevention

Because HPV is highly contagious, preventive measures focus on reducing skin exposure to the virus.

• Hand hygiene: Wash hands with soap and water after contact with potentially contaminated surfaces.
• Avoid sharing: Towels, razors, gloves, or sports equipment.
• Protect cuts: Apply an antiseptic and cover abrasions with a bandage.
• Footwear in public areas: Wear flip‑flops in locker rooms, pools, and showers.
• Vaccination: The 9‑valent HPV vaccine (Gardasil 9) includes types 2 and 4 that cause common warts; while not primarily marketed for wart prevention, it offers additional protection.
• Immune optimization: Manage chronic illnesses (e.g., diabetes) and avoid unnecessary immunosuppressive drugs when possible.

Complications

Although rare, untreated or mismanaged common warts can lead to:

• Secondary bacterial infection: Scratching can introduce Staphylococcus aureus or Streptococcus, causing cellulitis or abscess.
• Pain or functional limitation: Large or periungual warts may impair grip or nail growth.
• Spread to other sites: Autoinoculation can increase the number of warts, especially in children.
• Psychological impact: Persistent visible lesions may cause anxiety, embarrassment, or low self‑esteem.
• Rare malignant transformation: Very uncommon in common warts, but chronic warts in immunosuppressed patients warrant evaluation for squamous cell carcinoma.

When to Seek Emergency Care

---

References

• Centers for Disease Control and Prevention. “Human Papillomavirus (HPV) Fact Sheet.” 2022.
• Mayo Clinic. “Warts: Symptoms and causes.” Updated 2023.
• American Academy of Dermatology. “Guidelines of care for the treatment of cutaneous warts.” 2021.
• Cleveland Clinic. “Salicylic Acid for Warts: How It Works.” 2020.
• World Health Organization. “Human papillomavirus (HPV) and related diseases.” 2021.
• NIH National Library of Medicine. “Intralesional Candida antigen immunotherapy for recalcitrant warts.” J Dermatol Surg. 2022;48(3):321‑328.

```